Campistol, Josep M <br/><br/>
Minimizing the risk of posttransplant malignancy.  [electronic resource] 

 -  Transplantation  Apr 2009 
 - S19-22 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1534-6080 
<br/><br/><label>Standard No.: </label>10.1097/TP.0b013e3181a07a57  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Calcineurin Inhibitors<br/>Carcinoma, Renal Cell--prevention & control<br/>Cause of Death<br/>Female<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Kidney Neoplasms--prevention & control<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Neoplasms--chemically induced<br/>Postoperative Complications--epidemiology<br/>Protein Kinases--therapeutic use<br/>Risk Factors<br/>Sarcoma, Kaposi--prevention & control<br/>Sirolimus--therapeutic use<br/>Skin Neoplasms--prevention & control<br/>TOR Serine-Threonine Kinases